Mutations in Cancer Driver Genes: An Insight into Prostate Cancer Progression
Prostate cancer is one of the most common uro-oncological disease in men and is globally leading cause of cancer related deaths in males. The somatic mutation has a strong link in the occurrence of cancer. Mutation in the oncogenes and tumor suppressor genes that alter key cellular functions can lea...
| Main Authors: | , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Asian Medical Press Ltd.(H.K.)
2019-09-01
|
| Series: | Annals of Urologic Oncology |
| Subjects: | |
| Online Access: | http://auo.asmepress.com/articles/1032948_auo201909012.html |
| Summary: | Prostate cancer is one of the most common uro-oncological disease in men and is globally leading cause of cancer related deaths in males. The somatic mutation has a strong link in the occurrence of cancer. Mutation in the oncogenes and tumor suppressor genes that alter key cellular functions can lead to prostate cancer initiation and progression. Whole genome sequencing has identified numerous genetic alternations and further provided a detail view of the mutations in genes that drive progression of prostate cancer. TP53, SPOP, PTEN, ATM, AR, CTNNB1, FOXA1, KMT2D, BRACA2 and APC were found as frequently mutated genes in prostate cancer. Using data from cBioPortal and PubMed, this review summarizes the status and possible impact of mutations in these driver genes on survival, progression, and metastasis of prostate cancer. This study will contribute a better understanding of biological basis for clinical variability in prostate cancer patients and may provide new genetic diagnostic markers and drug targets. |
|---|---|
| ISSN: | 2617-7765 2617-7773 |